The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $112.46, a high ...

Leerink Partnrs analyst D. Graybosch anticipates that the company will post earnings per share of ($1.74) for the year. The consensus estimate for Nkarta’s current full-year earnings is ($1.68 ...

Leerink Partnrs analyst D. Graybosch forecasts that the biopharmaceutical company will post earnings per share of $1.72 for the quarter. Leerink Partnrs currently has a “Strong-Buy” rating on ...